03 Profile
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Learning disability & autism
Lucie Pellissier
Coordinator of the THERAUTISM project, National Centre for Scientific Research
press citation on 1 topic since 15 Jan 2026 · last quoted 15 Jan 2026
02 Quoted on · 1 of 29 topics
Lucie Pellissier: key facts
- Kind of voice
- Academic
- Role
- Coordinator of the THERAUTISM project, National Centre for Scientific Research
- Quoted on
- Learning disability & autism
- Tracked press citations
- 1
- Most recently quoted
- 15 Jan 2026
04 The signal · where Lucie Pellissier sits on learning disability & autism
Ranked 58= of 386 voices quoted in the press on learning disability & autism, level with 328 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Jon SparkesSector leaderChief Executive, Royal Mencap Society17
- 2
Professor Dame Uta FrithAcademicEmeritus Professor of Cognitive Development, UCL Institute of Cognitive Neuroscience, University College London8 - 3=Mel MerrittSector leaderHead of Policy and Influencing, National Autistic Society5
- 58=Prof Ian DouglasAcademicprofessor at the London School of Hygiene and Tropical Medicine1
- 58=Prof Jan HaavikClinicianmolecular neuroscientist and clinical psychiatrist at the University of Bergen1
- 58=Lucie PellissierAcademicCoordinator of the THERAUTISM project, National Centre for Scientific Research1
- 58=Michael SteinAcademicvisiting professor of law at the Harvard Law School and executive director of the Harvard Law School Project on Disability1
- 58=Tara EicherAcademicpostdoctoral research fellow at the Chan School1
Showing the leaders and the ranks around 58=, of 386 voices · See every voice on the topic →
05 On the record · press
What Lucie Pellissier has said
- cordis.europa.eu1
Where Lucie Pellissier has been quoted
- 01Drugs to treat the social symptoms of autism are getting closer | THERAUTISM Project | Results in Brief | H2020cordis.europa.eu · 15 Jan 2026
Verbatim
“Pharmacological treatments for core ASD features, ideally combined with behavioural interventions, are urgently needed. Yet despite significant research, no such drugs have been approved, with existing treatments only targeting co-occurring features such as irritability, anxiety or epilepsy.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.